长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02652 长风药业

未开盘 09-23 16:08:14

9.385

-0.915

-8.88%

最高10.380	最低9.320	成交量271.10万
今开10.330	昨收10.300	日振幅10.29%
总市值40.54亿	流通市值30.31亿	总股本4.32亿
成交额2,606万	换手率0.84%	流通股本3.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"长风药业","latestPrice":9.385,"timestamp":1790150894008,"preClose":10.3,"halted":0,"volume":2711000,"delay":0,"changeRate":-0.08883495145631076,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"未开盘","change":-0.915,"latestTime":"09-23 16:08:14","open":10.33,"high":10.38,"low":9.32,"amount":26057368,"amplitude":0.102913,"askPrice":9.39,"askSize":31200,"bidPrice":9.385,"bidSize":11000,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790213400000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":10.3,"openAndCloseTimeList":[[1790127000000,1790136000000],[1790139600000,1790150400000]],"volumeRatio":1.5375628126366134,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02652","defaultTab":"news","newsList":[{"id":"2669764421","title":"AI赋能源头创新，为肺部递送而设计，长风药业(02652)加码全球稀缺新机制吸入抗炎赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2669764421","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669764421?lang=zh_cn&edition=full","pubTime":"2026-09-23 09:30","pubTimestamp":1790127005,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，长风药业宣布，公司与一家由国内头部高校相关学科背景科学家团队创立、专注于AI辅助新药发现的科技企业签署研究合作协议。长风药业认为，这种“AI分子设计 + 肺部递送平台”的结合，有望成为吸入式创新药研发的重要新路径。本次合作是长风药业在创新吸入药物领域的又一前瞻性布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIPO","BK1191","CHAT","ARTY","159945","AGIX","VTHR","02652","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669528192","title":"长风药业(02652.HK)全球首创吸入新药ICF004顺利完成I期临床首例健康志愿者入组给药，产学研协同创新，加速本土原研突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2669528192","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669528192?lang=zh_cn&edition=full","pubTime":"2026-09-22 09:30","pubTimestamp":1790040640,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669164851","title":"长风药业：ICF004完成I期临床首例健康志愿者入组给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2669164851","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669164851?lang=zh_cn&edition=full","pubTime":"2026-09-21 22:59","pubTimestamp":1790002740,"startTime":"0","endTime":"0","summary":"南财智讯9月21日电，长风药业（02652.HK）发布自愿公告，公司研发的用于治疗间质性肺疾病（ILD）的吸入粉雾剂ICF004（化学药品第1类）I期临床试验已完成首名健康受试者的入组与给药工作，标志着该品种正式进入受试者给药阶段。ICF004采用吸入给药方式，旨在提高肺部局部药物暴露并降低全身药物暴露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609213880355870.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609213880355870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173893630","title":"长风药业（02652.HK）ICF004吸入粉雾剂完成I期临床首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1173893630","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173893630?lang=zh_cn&edition=full","pubTime":"2026-09-21 22:50","pubTimestamp":1790002254,"startTime":"0","endTime":"0","summary":"2026年9月21日，长风药业股份有限公司发布自愿公告称，公司自主研发、用于治疗间质性肺疾病的化学药品第1类吸入粉雾剂 ICF004 于近期完成 I 期临床试验首名健康受试者的入组并给药，标志着该项目正式进入临床给药阶段。根据公告，ICF004 采用吸入给药方式，意在直接将药物递送至肺部，以提高肺部局部药物暴露并降低全身暴露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667378766","title":"港股早盘低开高走 恒生指数半日上涨0.35% 药明生物（02269）涨4.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667378766","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667378766?lang=zh_cn&edition=full","pubTime":"2026-09-14 12:18","pubTimestamp":1789359482,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股早盘低开高走，截至午间收盘，恒生指数上涨0.35%；国企指数上涨0.4%，恒生科技指数上涨0.17%。医药概念板块表现强势，凯莱英涨10.88%，康龙化成涨5.15%，泰格医药涨7%，药明康德涨4.61%，药明生物涨4.81%。个股方面，联想集团股价扬升，半日涨4.6%。在中国x86服务器市场，第二季度，联想的x86服务器营收同比增长9.0%，以10.5%的市场份额排名第四。长风药业股价冲高回落，半日涨1.16%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MTYwMGM1ZDEwYjRjZDY4ZmI3MTk0ZDEyM2Y1MWFkMjMxODA4Mzk0Mzg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991494","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3063872942.SGD","HK0000320264.USD","LU0029875118.USD","BK1526","LU1242518857.USD","LU0708995583.HKD","BK1610","BK1191","LU0572940350.SGD","LU1785774172.SGD","LU1794554557.SGD","02652","LU0052750758.USD","LU1235295612.USD","LU0890818403.SGD","LU0791591158.USD","03419","02800","TCHI","LU0181495838.USD","LU1046422090.SGD","BK1607","09115","KURE","02269","LU0049112450.USD","LU0029874061.USD","SG9999002463.SGD","IE00B0JY6N72.USD","82800","513600","LU0370786039.SGD","MCHmain","BK1193","LU1366334651.USD","IE0032431581.USD","LU0456846285.SGD","WXXWY","LU2039709279.SGD","LU0140636845.USD","LU0823426480.USD","LU0128525689.USD","LU1720050803.USD","LU0310800965.SGD","LU0359202008.SGD","LU0456827905.SGD","SG9999002562.SGD","LU0862451837.USD","07300","03115","LU0417516902.SGD","LU0516422440.USD","HK0000306685.HKD","LU0791590937.USD","IE0003895053.USD","LU1808992512.USD","LU0572944931.SGD","LU0819121731.USD","00992","LU0516422952.EUR","LU0348825331.USD","LU0856984785.SGD","LU0572939691.SGD","LU1880383366.USD","HK0000306701.USD","LU0348735423.USD","LU0588546209.SGD","07500","HSI","LU0561508036.HKD","LU0052756011.USD","HSTECH","83115","IE0034224299.USD","07200","BK1576","LU0672654166.SGD","03037","LU0307460666.USD","LU2242644610.SGD","BK1141","LU0417516738.SGD","LU1688375341.USD","LU0516422366.SGD","LU0972618739.USD","LNVGY","LU0051755006.USD","LU0128526141.USD","LU0823426308.USD","LU0320764599.SGD","LU0039217434.USD","HK0000320223.HKD","LU1242518931.SGD","LU0128522157.USD","LU0516423174.USD","LU1366334578.USD","LU0320764755.SGD","LU0327786744.USD","LU0516423091.SGD","HHImain","LU1267930227.SGD","BK1521","BK1589","LU0543330483.HKD","LU0043850808.USD","LU0862451753.SGD","02833","LU0048580855.USD","LU0348827113.USD","LU0359201612.USD","LU0979878070.USD","LU0326950275.SGD","80992","LU0264606111.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667340776","title":"长风药业盘中涨逾10% ICF001四大适应症全覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=2667340776","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667340776?lang=zh_cn&edition=full","pubTime":"2026-09-14 11:25","pubTimestamp":1789356300,"startTime":"0","endTime":"0","summary":"模拟交易客户端长风药业今早走高，盘中最高涨逾10%，截至发稿，股价回落微涨1.06%，报10.47港元，成交额4207.14万港元。长风药业自研长效吸入粉雾剂候选药物ICF001近期连获多项临床试验默示许可，实现PAH、PH-ILD、IPF、PPF四大适应症全覆盖，成为国内首家将该类长效吸入前药推进至中国临床试验阶段的企业。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-14/doc-iniruhwy9581213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631770","title":"长风药业（02652）续涨3.76% ICF001拿到三项临床试验默示许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631770","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667631770?lang=zh_cn&edition=full","pubTime":"2026-09-14 10:16","pubTimestamp":1789352216,"startTime":"0","endTime":"0","summary":"金吾财讯 | 长风药业（02652）股价扬升，续涨3.76%，报10.75港元，成交额3166万港元。消息面上，长风药业自研创新药长效吸入粉雾剂ICF001接连拿到三项临床试验默示许可。截至目前，这款候选药物已覆盖PAH、PH-ILD、IPF、PPF四大适应症，也是国内首家将该类长效吸入前药推进至国内临床试验阶段的企业。公司董事长兼执行董事梁文青博士称，将同步开展海内外I期临床，积极布局海外合作开发、区域授权等全球化商业化路径。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991472","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BK1191","BMED","IBBJ","IBBQ","MDTX","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666420517","title":"港股异动 | 长风药业(02652)早盘大涨超10% ICF001多项适应症临床许可落地 公司将加快海内外I期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2666420517","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666420517?lang=zh_cn&edition=full","pubTime":"2026-09-11 10:07","pubTimestamp":1789092458,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长风药业早盘大涨超10%，截至发稿，涨8.23%，报10.39港元，成交额2874.43万港元。消息面上，近期，由长风药业自主研发的创新药长效吸入粉雾剂候选药物ICF001连获三项临床试验默示许可，至此，该创新药已实现PAH、PH-ILD、IPF、PPF四大适应症全覆盖，成为国内首家将该类长效吸入前药推进至中国临床试验阶段的企业。董事长兼执行董事梁文青博士表示，将同步推进海内外I期临床研究，并积极探索海外合作开发、区域授权等全球化路径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","BK1191","KCAI","VXUS","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121594981","title":"长风药业更新2026年8月股份变动月报表，注册股本增至4.34亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1121594981","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121594981?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:55","pubTimestamp":1788512147,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年9月4日披露了截至2026年8月31日的证券变动月报表，公布公司本期股本情况和发行人证券变动信息。根据报告，8月末公司注册股本由月初的302,223,586股H股与109,754,801股内资股，合计从411,978,387股增加至433,726,087股。公司截至本月底的H股中，库存股1,397,000股，无增减变化。公告显示，本次新增H股发行价格为每股港币13.82，已于2026年8月6日完成相关操作，经2026年6月26日股东大会审议通过。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663096940","title":"长风药业(02652)发布中期业绩，收益2.1亿元，同比增长2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663096940","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663096940?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:58","pubTimestamp":1788184711,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布2026年中期业绩，收益2.10亿元，同比增长2.1%，主要由于因集团 CF017产品在中东的客户基础及市场覆盖范围持续扩大，CF017产生的收益增加。商业化方面，报告期间集团已上市产品的市场表现受到政策安排、采购周期切换及渠道因素共同影响。报告期间，集团多个鼻科及呼吸产品取得监管进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489912.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662926130","title":"长风药业(02652)完成发行2174.77万股新H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662926130","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662926130?lang=zh_cn&edition=full","pubTime":"2026-08-28 23:43","pubTimestamp":1787931830,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年8月6日根据一般授权配发及发行2174.77万股新H股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172000579","title":"长风药业：配发及发行21,747,700股H股 占已发行股本约7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=1172000579","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172000579?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:16","pubTimestamp":1787926563,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年8月28日发布公告，称公司根据2026年7月31日签署的配售协议，并依据一般授权配发及发行21,747,700股新H股。该次新股发行变动日期为2026年8月6日，发行股份数量占此前已发行股份总数的约7.23%，每股发行价为13.82港元。发行完成后，公司已发行股份增至322,574,286股，库藏股数维持1,397,000股，发行人已发行股份总数为323,971,286股。长风药业确认，相关股份发行已符合香港联合交易所有限公司的上市规则以及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"长风药业：配发及发行21,747,700股H股 占已发行股本约7.23%","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662721758","title":"港股异动 | 长风药业(02652.HK)盘中拉升逾20% ICF001再获两项临床许可 产品长效吸入前药设计逻辑优势显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2662721758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662721758?lang=zh_cn&edition=full","pubTime":"2026-08-27 10:06","pubTimestamp":1787796377,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662072173","title":"港股异动 | 长风药业(02652)盘中拉升逾20% ICF001再获两项临床许可 产品长效吸入前药设计逻辑优势显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2662072173","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662072173?lang=zh_cn&edition=full","pubTime":"2026-08-27 10:06","pubTimestamp":1787796377,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长风药业盘中拉升逾20%，截至发稿，涨6.14%，报16.2港元，成交额5831.08万港元。消息面上，近日，长风药业宣布，集团自主研发的长效吸入干粉候选药物ICF001已获国家药监局就间质性肺病开展临床试验的默示许可。至此，ICF001实现PAH、PH-ILD、IPF、PPF四大适应症全覆盖。ICF001为肺部靶向前药制剂，长效吸入前药设计逻辑优势显著，此次新增两项新适应症临床研究将极大提升临床价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VXUS","BK1191","02652","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662831200","title":"港股异动 | 长风药业(02652)涨超5% ICF001实现IPF/PPF等四大适应症全覆盖 规划同步启动境内外I期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2662831200","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662831200?lang=zh_cn&edition=full","pubTime":"2026-08-25 09:46","pubTimestamp":1787622363,"startTime":"0","endTime":"0","summary":"长风药业(02652)涨超5%，截至发稿，涨5.46%，报16.06港元，成交额650.2万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260825/20260825094640_68825.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260825/20260825094640_68825.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484799.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02652","VXUS","BK1191","BK4588","KCAI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279454","title":"重大突破！长风药业(02652)ICF001再获两项临床许可 实现IPF/PPF等四大适应症全覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279454","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661279454?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:54","pubTimestamp":1787576046,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长风药业宣布，集团自主研发的长效吸入干粉候选药物ICF001已获国家药监局就间质性肺病开展临床试验的默示许可。至此，ICF001 实现PAH、PH-ILD、IPF、PPF 四大适应症全覆盖，产品定位与全球最新一代长效吸入前药研发方向高度对标，为公司后续全球多中心临床布局、注册策略规划、海外战略合作筑牢监管基础。ICF001 为肺部靶向前药制剂，长效吸入前药设计逻辑优势显著，此次新增两项新适应症临床研究将极大提升临床价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"重大突破！长风药业(02652)ICF001再获两项临床许可 实现IPF/PPF等四大适应症全覆盖","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119537580","title":"长风药业（02652）长效吸入干粉候选药物ICF001获批扩展IPF及PPF临床试验适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1119537580","media":"公告速递","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119537580?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:41","pubTimestamp":1787571672,"startTime":"0","endTime":"0","summary":"香港－2026年8月24日，长风药业股份有限公司发布自愿公告称，其自主研发的长效吸入干粉候选药物ICF001已获国家药品监督管理局就间质性肺病中两项适应症——特发性肺纤维化及进行性肺纤维化的临床试验默示许可。至此，ICF001已获准在肺动脉高压、间质性肺病相关肺高压、IPF及PPF四个适应症开展临床研究。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659180192","title":"港股午评|恒生指数早盘涨0.07%      医药板块涨幅领先","url":"https://stock-news.laohu8.com/highlight/detail?id=2659180192","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659180192?lang=zh_cn&edition=full","pubTime":"2026-08-13 12:00","pubTimestamp":1786593618,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.07，涨17点，报25457点；恒生科技指数涨0.30%。港股早盘成交1320亿港元。恒生创新药指数涨超2.6%；恒生生物科技指数涨超2.5%；其中，派格生物医药-B涨超8%；君实生物涨超7%；石药集团涨超5%。耐世特绩后涨超11%，中期权益持有人应占溢利同比增长35.17% ，正式推出HMDD。智谱涨超5%，获纳入MSCI中国指数，将于本月底生效；MINIMAX-W再涨超6%，近日正式入通并获纳入香港交易所科技100等指数。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999004303.SGD","BK1213","LU0348784397.USD","01316","LU0417516571.SGD","02800","LU0264606111.USD","07500","HHImain","ASMVY","LU0314109678.HKD","LU2039709279.SGD","BK1175","SGXZ23171101.USD","BK1191","LU1808992512.USD","LU0011963245.USD","02600","82800","LU1046421795.USD","LU2065170008.USD","LU2065171311.SGD","BK1144","LU0417516902.SGD","03115","BK1500","LU0211977185.USD","BK1501","LU0274383008.USD","LU0348766576.USD","MCHS","03419","300408","BK0222","LU2065169927.USD","00100","BK1169","LU0149534421.HKD","LU1282649810.SGD","07300","SG9999011746.SGD","08279","HSTECH","BK1509","LU0251143458.SGD","LU0648948544.HKD","02833","SG9999001903.USD","513600","LU0348783233.USD","LU1328277881.USD","LU2065171402.SGD","03296","03037","LU0417516738.SGD","BK0028","LU0227179875.USD","603296","LU1235294995.USD","HSI","09115","LU0348767384.USD","01910","LU0348735423.USD","06951","LU0540923850.HKD","BK1253","83115","MCHmain","LU0823040885.USD","BK1193","LU0572940350.SGD","LU0634319403.HKD","LU0702159699.USD","LU0593848301.USD","LU0384037296.USD","BK1614","00325","BK1577","00522","BK1170","BK1227","LU1282649067.USD","LU0348825331.USD","BK1568","LU0488056044.USD","LU1813983027.USD","002565","IE0008369823.USD","LU0607220059.USD","07200","SG9999000459.SGD","SG9999000475.SGD","BK1602","601600","02513","LU0702159343.USD","02652","BK1117","LU1823568750.SGD","SG9999004311.SGD","LU1880383366.USD","BK1592","HK0000286598.CNH","BK1513","LU1282649141.HKD","LU1166156734.SGD","01126","BK1155","BK1589","LU0572939691.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659218067","title":"长风药业午前涨超5% 完成配售2174.77万股新H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659218067","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659218067?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:50","pubTimestamp":1786593000,"startTime":"0","endTime":"0","summary":"模拟交易客户端长风药业午前涨超5%，截至发稿，股价上涨5.15%，现报16.94港元，成交额8531.80万港元。长风药业发布公告，已于2026年8月6日完成配售2174.77万股新H股，配售价每股H股13.82港元，净筹约2.95亿港元。据此前公司公告披露，其中净筹款项约70%用于集团创新候选药物的临床及临床前开发；约15%用于在全球范围内开发集团的复杂吸入制剂产品的CMC研究、临床研究、给药装置开发以及注册及监管申报开支。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-13/doc-ininctaw3431193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659187432","title":"港股异动 | 长风药业(02652.HK)涨超5% 完成配售2174.77万股新H股 ICF001有望填补治疗PH-ILD临床空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2659187432","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659187432?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:06","pubTimestamp":1786590384,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfpharmtech.com","stockEarnings":[{"period":"1week","weight":-0.0959},{"period":"1month","weight":-0.383},{"period":"3month","weight":-0.4927},{"period":"6month","weight":-0.5891},{"period":"1year","weight":-0.3637},{"period":"ytd","weight":-0.7319}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0761},{"period":"6month","weight":-0.0047},{"period":"1year","weight":-0.0507},{"period":"ytd","weight":-0.0311}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长风药业股份有限公司是一家主要从事呼吸系统药物及其他相关医疗产品的研发、生产及销售的中国公司。该公司的产品组合主要针对呼吸系统疾病，包括哮喘、慢性阻塞性肺病（COPD）和过敏性鼻炎。该公司主要产品包括CF017，即治疗支气管哮喘的吸入用布地奈德混悬液，以及CF018，一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"长风药业","nameEN":"CF PHARMTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长风药业,02652,长风药业股票,长风药业股票老虎,长风药业股票老虎国际,长风药业行情,长风药业股票行情,长风药业股价,长风药业股市,长风药业股票价格,长风药业股票交易,长风药业股票购买,长风药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}